Medical plaster bandage testing verifies the setting behavior, mechanical strength, chemical purity, and biocompatibility of plaster of Paris (gypsum) casting products used for orthopedic fracture fixation and immobilization. Accredited third-party laboratories evaluate these devices against recognized standards such as YY 1117, ISO 10993, GB/T 16886, and ISO 11607 to support regulatory registration, batch quality control, and market access. This article explains the scope of testing, sample types, key test items, laboratory methods, and frequently asked questions for medical plaster bandages.
Technical Overview
Medical plaster bandages, commonly known as plaster of Paris bandages or gypsum bandages, are non-invasive orthopedic fixation devices consisting of calcined gypsum (calcium sulfate hemihydrate, CaSO4·1/2H2O) uniformly distributed on a woven gauze substrate. When the bandage is immersed in water and wrapped around a limb, the hemihydrate rehydrates to calcium sulfate dihydrate (CaSO4·2H2O) through an exothermic crystallization reaction, producing a rigid, load-bearing cast within minutes.
Because the clinical performance of a cast depends directly on this hydration chemistry and on the quality of the gauze carrier, laboratory testing focuses on setting kinetics, heat generation, mechanical strength of the hardened cast, chemical purity of the gypsum, and biological safety of all patient-contacting materials. In most jurisdictions these products are regulated as medical devices (for example, Class II in China under NMPA, and medical devices under the EU MDR and FDA frameworks), so testing results typically feed into product registration dossiers, technical documentation, and routine quality control.
Testing Samples
Plaster of Paris Bandage Rolls
Finished rolls of impregnated gauze in the manufacturer's marketed configurations, typically widths from 5 cm to 20 cm and lengths from approximately 2.7 m to 4.6 m. Samples are taken from at least three production batches, including lots at the beginning and end of the claimed shelf life, to capture batch-to-batch and aging variability.
Synthetic Casting Tapes
Polyurethane-resin-impregnated fiberglass or polyester casting tapes, which are increasingly used as lightweight alternatives to plaster, are tested for analogous properties such as setting (curing) time, exotherm, cured strength, and resin content, using manufacturer specifications and relevant ISO/ASTM methods as the basis of evaluation.
Raw Materials and Components
Calcined gypsum powder (verified for hemihydrate purity, free moisture, and phase composition), bleached cotton or cotton-polyester gauze (thread count, mass per unit area), and any padding, stockinette, or liner materials supplied with the bandage system.
Packaging and Labeling
Primary moisture-barrier packaging, secondary cartons, labels, and instructions for use, which are evaluated for integrity, seal performance, moisture protection, and compliance with declared storage conditions and expiry dating.
Testing Items
A typical test program for medical plaster bandages covers the following items, selected according to the applicable product standard (for example YY 1117 for plaster bandages) and the intended-use risk assessment:
- Appearance, roll dimensions, length, width, and mass uniformity
- Gypsum (plaster) content per unit area and impregnation uniformity across the roll
- Gauze construction: thread count, fabric mass per unit area, and yarn specification
- Setting time after standardized water immersion
- Hardening time and strength development of the formed cast
- Peak exothermic setting temperature (skin-burn risk control)
- Water immersion performance: wetting time, water absorption, and water retention
- Wet and dry compressive (crush) strength of cylindrical cast specimens
- Flexural strength, delamination resistance, and layer-to-layer bonding of hardened casts
- Linear setting expansion and dimensional stability
- Chemical composition: calcium sulfate hemihydrate content, free moisture, phase purity by X-ray diffraction
- Heavy metals, arsenic, acid-insoluble impurities, and pH of aqueous extracts
- Biocompatibility: cytotoxicity, skin sensitization, and intracutaneous irritation
- Microbial limits (bioburden) for non-sterile product, or sterility testing where a sterile claim is made
- Primary packaging seal strength and integrity
- Shelf-life confirmation through real-time and accelerated aging
- Labeling, symbols, and instructions-for-use compliance
Testing Methods
Physical and Mechanical Testing
Specimens are conditioned in a standard laboratory atmosphere (for example 23 °C ± 2 °C and 50 % ± 10 % relative humidity per ISO 291) before immersion testing. Setting time is determined by immersing pre-weighed bandage samples in water at a controlled temperature (commonly 20–25 °C) and recording the interval from immersion to the loss of plasticity, using procedures adapted from the product standard and from gypsum physical test methods such as ASTM C472. Peak setting temperature is captured with an embedded thermocouple or infrared probe at the core of a wrapped specimen. Hardened cast performance is measured on ring or strip specimens formed under standardized conditions: crush strength is measured by diametral compression between parallel platens on a universal testing machine, while flexural strength and delamination resistance are assessed by three-point bending. The mass of gypsum retained on the gauze is verified by dissolving or washing the set plaster from a known area of fabric.
Chemical and Compositional Analysis
Calcium sulfate content is determined by complexometric titration or gravimetric methods, and the relative proportions of hemihydrate, dihydrate, and anhydrite phases are confirmed by X-ray diffraction and thermogravimetric analysis. Free moisture is quantified gravimetrically, since excess moisture accelerates premature setting and degrades storage stability. Heavy metals and arsenic are screened by inductively coupled plasma optical emission spectrometry (ICP-OES) or atomic absorption spectroscopy against limits derived from the toxicological risk assessment and ISO 10993-17 principles. The pH of the aqueous extract is measured using methods consistent with GB/T 14233.1, and laboratory water of defined grade (for example ISO 3696 Grade 2) is used for all extraction steps.
Biocompatibility Evaluation
Plaster bandages are surface-contacting devices with prolonged contact duration (up to 30 days), so the biological evaluation plan per ISO 10993-1 and the GB/T 16886 series typically includes in vitro cytotoxicity (ISO 10993-5, extract/MTT method), skin sensitization (ISO 10993-10, guinea pig maximization or local lymph node assay), and intracutaneous irritation (ISO 10993-23). A documented chemical characterization and toxicological risk assessment may be used to justify any endpoint reduction.
Microbiological and Sterility Testing
Most plaster bandages are supplied non-sterile and applied over protective padding; for these products, microbial limits (total aerobic count, mold and yeast count, and absence of specified objectionable organisms) are verified using methods such as GB/T 14233.2 or ISO 11737-1. If the product is labeled sterile, sterility assurance is demonstrated per ISO 11737-2 together with validation of the sterilization process.
Packaging and Shelf-Life Validation
Because calcined gypsum is moisture-sensitive, primary packaging performance is critical. Seal strength is measured per ASTM F88, seal and channel defects are detected by dye penetration (ASTM F1929) or internal pressurization (ASTM F2096), and package integrity is confirmed per ISO 11607 and the equivalent GB/T 19633 series. Shelf life is substantiated through accelerated aging per ASTM F1980 combined with real-time storage studies, after which setting time, strength, and microbial attributes are re-verified against initial acceptance criteria.
Applications
Testing of medical plaster bandages supports the entire product life cycle, from development to post-market surveillance:
- Registration and type testing for regulatory submissions (for example NMPA Class II registration, EU MDR technical documentation, and FDA submissions)
- Manufacturer quality control, including incoming gypsum and gauze inspection, in-process monitoring, and finished-product release testing
- Supplier change evaluation and comparative benchmarking of alternative gauze or plaster sources
- Shelf-life establishment and verification of expiration dating claims
- Complaint and failure investigation, such as casts that crumble, set too slowly, or overheat during application
- Hospital procurement acceptance checks and third-party market surveillance testing by accredited laboratories
- Research and development of improved formulations, including fast-setting and low-exotherm grades
FAQ
What setting time and setting temperature are acceptable?
Conventional plaster bandages typically set in roughly 5 to 10 minutes, while fast-setting grades are designed for approximately 2 to 4 minutes, allowing initial weight bearing within 10 to 30 minutes. Peak setting temperature should remain below approximately 45 °C to minimize the risk of low-temperature burns; exact limits must be taken from the applicable product standard and the manufacturer's validated specification.
Do plaster bandages have to be sterile?
Not necessarily. Most plaster bandages are placed over stockinette and padding and are supplied non-sterile, in which case microbial limit testing is performed instead of sterility testing. If a sterile claim is made on the label, the product must pass sterility testing and the sterilization process must be validated in accordance with ISO 11737-2.
Which biocompatibility tests are usually required?
For a skin-contacting, externally applied device with contact up to 30 days, the typical baseline is cytotoxicity, sensitization, and intracutaneous irritation per the ISO 10993 / GB/T 16886 series, supported by chemical characterization and toxicological risk assessment of the gypsum and gauze materials.
How much sample is needed and how long does testing take?
Physical, chemical, and packaging testing generally requires several full rolls per batch (commonly 10 to 30 rolls across three batches, depending on the test scope) and can be completed within a few weeks. Biocompatibility studies may require 6 to 12 weeks, and shelf-life confirmation depends on the claimed storage period and the aging protocol selected.
How do synthetic casting tapes differ in testing?
Synthetic tapes replace gypsum hydration with polyurethane moisture-cure chemistry, so testing emphasizes resin content, curing time, cured laminate strength, radiolucency, and isocyanate-related chemical safety, while the biocompatibility, packaging, and shelf-life principles remain largely the same as for plaster bandages.